1. Home
  2. FRHC vs RGEN Comparison

FRHC vs RGEN Comparison

Compare FRHC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRHC
  • RGEN
  • Stock Information
  • Founded
  • FRHC 1981
  • RGEN 1981
  • Country
  • FRHC United States
  • RGEN United States
  • Employees
  • FRHC N/A
  • RGEN N/A
  • Industry
  • FRHC Investment Bankers/Brokers/Service
  • RGEN Medical/Dental Instruments
  • Sector
  • FRHC Finance
  • RGEN Health Care
  • Exchange
  • FRHC Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • FRHC 7.8B
  • RGEN 8.0B
  • IPO Year
  • FRHC N/A
  • RGEN N/A
  • Fundamental
  • Price
  • FRHC $169.00
  • RGEN $118.15
  • Analyst Decision
  • FRHC
  • RGEN Buy
  • Analyst Count
  • FRHC 0
  • RGEN 12
  • Target Price
  • FRHC N/A
  • RGEN $172.67
  • AVG Volume (30 Days)
  • FRHC 98.4K
  • RGEN 819.3K
  • Earning Date
  • FRHC 06-13-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • FRHC N/A
  • RGEN N/A
  • EPS Growth
  • FRHC N/A
  • RGEN N/A
  • EPS
  • FRHC 5.36
  • RGEN N/A
  • Revenue
  • FRHC $1,578,152,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • FRHC N/A
  • RGEN $13.93
  • Revenue Next Year
  • FRHC N/A
  • RGEN $14.35
  • P/E Ratio
  • FRHC $32.16
  • RGEN N/A
  • Revenue Growth
  • FRHC 79.07
  • RGEN 4.88
  • 52 Week Low
  • FRHC $71.88
  • RGEN $102.97
  • 52 Week High
  • FRHC $185.00
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • FRHC 62.09
  • RGEN 38.20
  • Support Level
  • FRHC $138.99
  • RGEN $120.11
  • Resistance Level
  • FRHC $185.00
  • RGEN $129.42
  • Average True Range (ATR)
  • FRHC 5.31
  • RGEN 6.02
  • MACD
  • FRHC 0.70
  • RGEN -1.20
  • Stochastic Oscillator
  • FRHC 58.97
  • RGEN 5.96

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: